GPT and cancer: Similarly, a comparison of ALT to hepatocyte cfDNA levels in 47 patients with cancer with liver metastases yielded Spearman’s correlation coefficient of 0.6 and P < 0.0001, supporting the validity of hepatocyte cfDNA methylation markers in the setting of liver metastasis (Figure 1F).